Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.

Saved in:
Bibliographic Details
Title: Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.
Authors: Hensing TA; NorthShore University Health System Kellogg Cancer Center, University of Chicago, Evanston, Illinois., Wang X; Alliance Statistics and Data Center, Duke University, Durham, North Carolina., Stinchcombe TE; Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina., Gao J; Alliance Statistics and Data Center, Duke University, Durham, North Carolina., Knopp MV; Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, Ohio., Watson M; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri., Dudek AZ; HealthPartners Cancer Care Center, St. Paul, Minnesota., Graziano SL; SUNY Upstate Medicine University, Syracuse, New York., Patel JD; Lurie Cancer Center Northwestern University, Chicago, Illinois., Faller BA; Missouri Baptist Medical Center, St. Louis, Missouri., Dragnev KH; Dartmouth-Hitchcock Norris Cotton Cancer Center, Lebanon, New Hampshire., Kozono D; Dana-Farber/Partners Cancer Care, Boston, Massachusetts., Vokes EE; Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.
Source: JTO clinical and research reports [JTO Clin Res Rep] 2021 Jul 13; Vol. 2 (8), pp. 100208. Date of Electronic Publication: 2021 Jul 13 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-3643
DOI:10.1016/j.jtocrr.2021.100208